Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the preven... von Aapro, M., Fabi, A., Nolè, F., Medici, M., Steger, G., Bachmann, C., Roncoroni, S., Roila, F.

Volltext

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma... von Bossi, P., Miceli, R., Locati, L.D., Ferrari, D., Vecchio, S., Moretti, G., Denaro, N., Caponigro, F., Airoldi, M., Moro, C., Vaccher, E., Sponghini, A., Caldara, A., Rinaldi, G., Ferrau, F., Nolè, F., Lo Vullo, S., Tettamanzi, F., Hollander, L., Licitra, L.

Volltext

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving hig... von Bossi, P., Cortinovis, D., Fatigoni, S., Cossu Rocca, M., Fabi, A., Seminara, P., Ripamonti, C., Alfieri, S., Granata, R., Bergamini, C., Agustoni, F., Bidoli, P., Nolè, F., Pessi, M.A., Macchi, F., Michellini, L., Montanaro, F., Roila, F.

Volltext

Cancer–testis antigen expression in triple-negative breast cancer von Curigliano, G., Viale, G., Ghioni, M., Jungbluth, A.A., Bagnardi, V., Spagnoli, G.C., Neville, A.M., Nolè, F., Rotmensz, N., Goldhirsch, A.

Volltext

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer von Munzone, Elisabetta, Botteri, E., Sciandivasci, A., Curigliano, G., Nolè, F., Mastropasqua, M., Rotmensz, N., Colleoni, M., Esposito, A., Adamoli, L., Luini, A., Goldhirsch, A., Viale, G.

Volltext

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects von Colleoni, M., Orlando, L., Sanna, G., Rocca, A., Maisonneuve, P., Peruzzotti, G., Ghisini, R., Sandri, M.T., Zorzino, L., Nolè, F., Viale, G., Goldhirsch, A.

Volltext

A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma von Rocca, A, Minucci, S, Tosti, G, Croci, D, Contegno, F, Ballarini, M, Nolè, F, Munzone, E, Salmaggi, A, Goldhirsch, A, Pelicci, P G, Testori, A

Volltext

Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how? von Marvaso, G., Corrao, G., Oneta, O., Pepa, M., Zaffaroni, M., Corso, F., Gandini, S., Cecconi, A., Zerini, D., Mazzola, G. C., Augugliaro, M., Cossu Rocca, M., Verri, E., Cattani, F., La Fauci, F., Bergamaschi, L., Luzzago, S., Mistretta, A. F., Musi, G., Nolè, F., De Cobelli, O., Orecchia, R., Jereczek-Fossa, B. A.

Volltext

Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort von Fornarini, G., Rebuzzi, S.E., Banna, G.L., Calabrò, F., Scandurra, G., De Giorgi, U., Masini, C., Baldessari, C., Naglieri, E., Caserta, C., Manacorda, S., Maruzzo, M., Milella, M., Buttigliero, C., Tambaro, R., Ermacora, P., Morelli, F., Nolè, F., Astolfi, C., Sternberg, C.N.

Volltext

Very young women (<35 years) with operable breast cancer: features of disease at presentation von COLLEONI, M, ROTMENSZ, N, CATALANO, G, GALIMBERTI, V, NOLE, F, MARTINELLI, G, GOLDHIRSCH, A, ROBERTSON, C, ORLANDO, L, VIALE, G, RENNE, G, LUINI, A, VERONESI, P, INTRA, M, ORECCHIA, R

Volltext

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99 von Pagani, O., Klingbiel, D., Ruhstaller, T., Nolè, F., Eppenberger, S., Oehlschlegel, C., Bernhard, J., Brauchli, P., Hess, D., Mamot, C., Munzone, E., Pestalozzi, B., Rabaglio, M., Aebi, S., Ribi, K., Rochlitz, C., Rothgiesser, K., Thürlimann, B., von Moos, R., Zaman, K., Goldhirsch, A.

Volltext

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial von Ghi, M.G., Paccagnella, A., Ferrari, D., Foa, P., Alterio, D., Codecà, C., Nolè, F., Verri, E., Orecchia, R., Morelli, F., Parisi, S., Mastromauro, C., Mione, C.A., Rossetto, C., Polsinelli, M., Koussis, H., Loreggian, L., Bonetti, A., Campostrini, F., Azzarello, G., D’Ambrosio, C., Bertoni, F., Casanova, C., Emiliani, E., Guaraldi, M., Bunkheila, F., Bidoli, P., Niespolo, R.M., Gava, A., Massa, E., Frattegiani, A., Valduga, F., Pieri, G., Cipani, T., Da Corte, D., Chiappa, F., Rulli, E.

Volltext

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels von COLLEONI, M, ROCCA, A, DE BRAUD, F, VIALE, G, GOLDHIRSCH, A, SANDRI, M. T, ZORZINO, L, MASCI, G, NOLE, F, PERUZZOTTI, G, ROBERTSON, C, ORLANDO, L, CINIERI, S

Volltext

Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experienc... von Alterio, D., Cossu Rocca, M., Russell-Edu, W., Dicuonzo, S., Fanetti, G., Marvaso, G., Preda, L., Zorzi, S., Verri, E., Nole’, F., Jereczek-Fossa, B. A.

Volltext

Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer von Sanna, G, Preda, L, Bruschini, R, Cossu Rocca, M, Ferretti, S, Adamoli, L, Verri, E, Franceschelli, L, Goldhirsch, A, Nolè, F

Volltext

Should liver metastases of breast cancer be biopsied to improve treatment choice? von Curigliano, G., Bagnardi, V., Viale, G., Fumagalli, L., Rotmensz, N., Aurilio, G., Locatelli, M., Pruneri, G., Giudici, S., Bellomi, M., Della Vigna, P., Monfardini, L., Orsi, F., Nolè, F., Munzone, E., Goldhirsch, A.

Volltext

Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors von Sanna, G., Lorizzo, K., Rotmensz, N., Bagnardi, V., Cinieri, S., Colleoni, M., Nolè, F., Goldhirsch, A.

Volltext

Sunitinib 2 weeks on, 1 off: strengths and weaknesses von Iacovelli, R., Verri, E., Cossu Rocca, M., Aurilio, G., Cullurà, D., Nolé, F.

Volltext

Activity of fulvestrant in HER2-overexpressing advanced breast cancer von Robertson, J.F.R., Steger, G.G., Neven, P., Barni, S., Gieseking, F., Nolè, F., Pritchard, K.I., O'Malley, F.P., Simon, S.D., Kaufman, B., Petruzelka, L.

Volltext

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications von Nolé, F., Munzone, E., Zorzino, L., Minchella, I., Salvatici, M., Botteri, E., Medici, M., Verri, E., Adamoli, L., Rotmensz, N., Goldhirsch, A., Sandri, M. T.

Volltext